Patra NeurosurgicalPatient education

Procedure

Responsive neurostimulation (RNS)

An implanted device that watches brain activity at the place where seizures start and sends brief pulses when it detects a seizure pattern. Its goal is fewer seizures over time.

How this page was written
Compiled from the sources cited on the page, with AI drafting assistance
Clinical review
Not individually reviewed by a clinician. How pages are written
Last updated
November 17, 2026

General information, not medical advice. In an emergency call 911. Full disclaimer

What it does

A small computer called a neurostimulator is placed in the skull. It connects to one or two thin wires (leads) placed at or near the spots where seizures start. The device senses brain activity all the time. The doctor programs it to recognize patterns that come at the start of a seizure. When it detects one, it sends brief pulses of electricity. [1]

In long-term follow-up, people had an average of about 1,000 detections a day, but stimulation added up to only about 3 to 4 minutes a day on average. [1]

The FDA-approved device studied in the trials below is the NeuroPace RNS System. [2] [1]

When it is considered

The FDA approved this device for adults 18 and older who have all of these:

It was tested in people with an average of 3 or more disabling seizures a month. It has not been studied in people with fewer seizures. It is approved as an add-on to medicine. [2]

RNS may be an option when surgery to remove the seizure area would carry too much risk, or is unlikely to help enough. [1]

Uses outside the FDA approval. Using RNS in people under 18, for generalized epilepsy, or with leads placed in the thalamus (a relay area deep in the brain) is outside the approved labeling. These uses are off label or investigational. [2] Ask your team what evidence supports any such plan for you.

What matters most in the decision

RNS aims to reduce seizures. Seizure freedom is possible but less common. The benefit tends to build over years, not weeks. [1] Surgery that removes the seizure area offers a higher chance of seizure freedom when it is possible. [1]

Preparation and what happens

You first need an epilepsy surgery evaluation to find where seizures start. Some people need stereo-EEG first. During surgery, the surgeon places the leads and fits the neurostimulator into the skull. [1]

Expected benefits

Fewer seizures (randomized trial). The main trial included 191 adults. For 12 weeks, half had the device turned on and half had it off, without knowing which. Seizures fell by about 38% with stimulation and about 17% without. Quality of life improved, and tests showed no worsening of mood or thinking. [3]

Fewer seizures over time (long-term study). Of 256 adults in the early trials, 230 joined a follow-up study lasting up to 9 years. At 9 years:

[1]

Seizure freedom. Over the 9 years, 18 out of 100 people (47 of 256) had at least one full year with no seizures. Among people with enough diary data at 9 years, 21 out of 100 were seizure free in the last 6 months. [1]

Quality of life stayed improved through 9 years. [1]

These later results come from an open study without a comparison group, so they may overstate the benefit. [1]

Risks and complications

Infection. Infection happened after about 4 out of 100 procedures (first implant, battery replacement, or revision). Over the whole study, 12 out of 100 people had a serious infection at the implant site. Nearly half of these infections led to removal of the device. [1]

Bleeding. Bleeding not caused by a seizure occurred in 7 of 256 people, about 3 out of 100. [1]

Mood and memory. Many people in the studies already had depression before the implant. Most mood problems reported were not judged to be device related. Memory complaints were mostly mild and mostly in people who had memory problems before. [1]

MRI scans. In 2020 the FDA approved MRI labeling for the RNS-320 model. It allows full-body 1.5 tesla MRI only under specific conditions. [4] Always tell the MRI staff about your device, and check with your epilepsy team before any scan.

Alternatives

Recovery and follow-up

Keep taking your medicine as prescribed. Any plan to change your medicine should come from your treating team. Recovery varies. Follow the discharge instructions from your own team.

Questions to ask

  1. Where would the leads go, and why there?
  2. What results should I expect in the first year, and later?
  3. How often will I need programming visits?
  4. How long will the battery last with my settings?
  5. What are the MRI rules for my device?

Sources

  1. Nair DR, Laxer KD, Weber PB, et al. Nine-year prospective efficacy and safety of brain-responsive neurostimulation for focal epilepsy. Neurology. 2020;95(9):e1244-e1256. Published September 1, 2020. Open source
  2. Premarket Approval P100026: NeuroPace RNS System. US Food and Drug Administration. Published November 14, 2013. Open source
  3. Morrell MJ; RNS System in Epilepsy Study Group. Responsive cortical stimulation for the treatment of medically intractable partial epilepsy. Neurology. 2011;77(13):1295-1304. Published September 1, 2011. Open source
  4. NeuroPace RNS System receives FDA approval for MRI labeling. NeuroPace press release via Business Wire. 9 March 2020. Published March 9, 2020. Open source